| Literature DB >> 33801116 |
Irimia Mollinedo-Cardalda1, Adriana López Rodríguez2, Manuela Ferreira3, José María Cancela-Carral4.
Abstract
BACKGROUND: The proportion of older adults is increasing worldwide and, with it, the physical inactivity common to this age group. Therefore, the promotion of active aging is a strategic factor in health policies for older people. The aim of this study was to identify the benefits and viability of the strength training program (STRENOLD) in health-related quality of life in adults over 60.Entities:
Keywords: older adults; physical exercise; quality of life; strength; training
Year: 2021 PMID: 33801116 PMCID: PMC8004100 DOI: 10.3390/ijerph18063253
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Sample Characteristics by Countries.
| All Countries | Bulgaria | Hungary | Italy | Spain | Chi-Square/Anova | |
|---|---|---|---|---|---|---|
|
| ||||||
| Female | 79.40 | 84.20 | 78.20 | 77.70 | 77.50 | Chi = 6.508 |
| Male | 20.60 | 15.80 | 21.80 | 22.30 | 22.50 | |
|
| 69.24 (6.94) | 70.14 (7.78) | 66.42 (5.94) | 69.17 (7.37) | 71.21 (6.67) | F = 6.833 |
|
| ||||||
| Primary school | 40.80 | - | - | 38.70 | 42.90 | Chi = 56.266 |
| High school | 53.62 | 63.20 | 54.50 | 50.00 | 46.80 | |
| University | 25.60 | 36.80 | 45.50 | 9.70 | 10.30 | |
| Doctorate | 1.60 | - | - | 1.60 | - | |
|
| ||||||
| Parkinson | 2.00 | - | - | - | 2.00 | Chi = 70.754 |
| Cognitive impairment | 2.90 | 3.80 | - | - | 2.00 | |
| Multiple sclerosis | - | - | - | - | - | |
| Hypertension | 43.87 | 54.00 | 48.80 | 36.70 | 36.00 | |
| Asthma | 3.20 | - | 0.80 | - | 5.60 | |
| Chronic obstructive pulmonary disease | 4.82 | 3.20 | 5.50 | 6.00 | 4.60 | |
| Low back pain | 3.50 | 2.00 | - | - | 5.00 | |
| Osteoporosis | 13.80 | 14.40 | 12.20 | - | 14.80 | |
| Diabetes | 8.42 | 2.00 | 4.20 | 3.50 | 24.00 | |
| Cancer | 16.90 | 13.60 | 24.50 | 23.50 | 6.00 | |
| Others | 5.10 | 7.30 | 4.00 | 4.00 | - |
Feasibility of STRENOLD program.
| All Countries | Bulgaria | Hungary | Italy | Spain | Chi Square | |
|---|---|---|---|---|---|---|
| Recruitment rate (%) | 64.26 | 52.32 | 94.44 | 55.17 | 55.10 | Chi = 18.46; |
| Participation rate (%) | 90.07 | 91.65 | 82.25 | 95.67 | 90.74 | Chi = 4.59; |
| Adherence (%) | 91.14 | 89.67 | 91.15 | 90.10 | 93.67 | Chi = 3.13; |
| Dropout (%) | 3.09 | 6.33 | 0.00 | 4.16 | 1.85 | Chi = 9.35; |
| Safety and tolerability (%) | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | - |
EQ-5D-5L health state.
| EQ-5D-5L Health State | Baseline | Post Intervention | EQ-VAS Score | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MO | SC | UA | PD | AD | N | Cumulative % |
| Cumulative % | Mean Difference | Student’s t | Cohen’s d |
| 1 | 1 | 1 | 1 | 1 | 96 | 28.50 | 108 | 32.10 | 1.76 | t = 2.60 | d = 0.19 |
| 1 | 1 | 1 | 2 | 1 | 30 | 37.40 | 34 | 42.20 | 0.99 | t = 1.03 | d = 0.10 |
| 1 | 1 | 1 | 1 | 2 | 19 | 43.00 | 11 | 45.50 | 2.08 | t = 3.28 | d = 0.22 |
| 1 | 1 | 1 | 2 | 2 | 17 | 48.00 | 17 | 50.60 | 0.03 | t = 0.57 | d = 0.01 |
| 2 | 1 | 1 | 2 | 1 | 17 | 53.00 | 19 | 56.30 | 3.65 | t = 2.65 | d = 0.38 |
| 1 | 1 | 1 | 3 | 1 | 11 | 56.30 | 3 | 57.20 | 3.57 | t = 2.55 | d = 0.54 |
| 1 | 1 | 1 | 2 | 3 | 7 | 58.40 | 2 | 57.80 | 1.28 | t = 1.87 | d = 0.23 |
| 3 | 3 | 3 | 3 | 3 | 7 | 60.50 | 7 | 59.90 | 0.21 | t = 0.77 | d = 0.02 |
| 2 | 1 | 1 | 1 | 1 | 6 | 62.30 | 5 | 61.40 | 1.64 | t = 1.98 | d = 0.17 |
| 1 | 1 | 1 | 3 | 3 | 5 | 63.80 | 0 | 61.40 | - | - | - |
| 2 | 1 | 1 | 2 | 2 | 5 | 65.30 | 13 | 65.30 | 3.93 | t = 2.11 | d = 0.41 |
| 2 | 1 | 1 | 3 | 2 | 5 | 66.80 | 0 | 65.30 | - | - | - |
| 2 | 1 | 2 | 2 | 2 | 4 | 68.00 | 8 | 67.70 | 2.75 | t = 2.01 | d = 0.28 |
| 1 | 1 | 1 | 1 | 3 | 3 | 68.90 | 1 | 68.00 | 23.75 | t = 3.87 | d = 0.55 |
| 1 | 1 | 2 | 2 | 1 | 3 | 69.80 | 5 | 69.50 | 3.25 | t = 1.95 | d = 0.33 |
| 1 | 1 | 2 | 2 | 2 | 3 | 70.70 | 3 | 70.40 | 5 | t = 2.88 | d = 0.51 |
| 2 | 1 | 2 | 3 | 1 | 3 | 71.60 | 1 | 70.70 | 7.5 | t = 3.12 | d = 0.77 |
| 2 | 1 | 2 | 3 | 3 | 3 | 72.50 | 0 | 70.70 | - | - | - |
| 4 | 4 | 4 | 4 | 4 | 3 | 73.40 | 0 | 71.60 | - | - | - |
Obs: AD, anxiety/depression; ES, Effect Size; MO, mobility; PD, pain/discomfort; SC, self-care; UA, usual activities; VAS, visual analogic scale. The Bonferroni correction for multiple comparisons was applied.
EQ-5D-5L health state. Effects of the STRENOLD Program by country.
| EQ-5D-5L Health State | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mobility | Self-Care | Usual Activities | Pain-Discomfort | Anxiety Depression | Index Score | EQ-VAS Score | ||
|
| Baseline | 1.65 (0.86) | 1.24 (0.61) | 1.43 (0.74) | 1.94 (0.89) | 1.67 (0.93) | 0.82 (0.19) | 74.18 (16.65) |
| Post intervention | 1.47 (0.78) | 1.23 (0.60) | 1.32 (0.64) | 1.83 (0.79) | 1.51 (0.74) | 0.83 (0.17) | 77.69 (17.37) | |
| Paired | t = 1.76; | t = 0.93; | t = 2.01; | t = 1.91; | t = 2.44; | t = 0.19; | t = 1.19; | |
| ES: Cohen’s d | d = 0.22 | d = 0.02 | d = 0.16 | d = 0.14 | d = 0.19 | d = 0.05 | d = 0.31 | |
|
| Baseline | 2.08 (0.95) | 1.71 (0.96) | 2.07 (0.97) | 2.43 (0.88) | 2.18 (1.05) | 0.67 (0.24) | 65.12 (16.03) |
| Post intervention | 1.87 (0.81) | 1.76 (0.85) | 1.91 (0.82) | 2.13 (0.64) | 1.92 (0.73) | 0.70 (0.18) | 71.04 (14.13) | |
| Paired | t = 0.89; | t = 0.32; | t = 1.01; | t = 2.98; | t = 3.05; | t = 1.05; | t = 1.93; | |
| ES: Cohen’s d | d = 0.26 | d = 0.05 | d = 0.18 | d = 0.39 | d = 0.29 | d = 0.14 | d = 0.39 | |
|
| Baseline | 1.44 (0.76) | 1.05 (0.40) | 1.13 (0.47) | 1.47 (0.74) | 1.22 (0.53) | 0.91 (0.16) | 81.78 (12.05) |
| Post intervention | 1.24 (0.64) | 1.03 (0.16) | 1.06 (0.23) | 1.35 (0.59) | 1.06 (0.23) | 0.95 (0.08) | 81.49 (18.02) | |
| Paired | t = 2.05; | t = 1.11; | t = 1.56; | t = 1.87; | t = 2.45; | t = 0.21; | t = 0.67; | |
| ES: Cohen’s d | d = 0.28 | d = 0.06 | d = 0.19 | d = 0.18 | d = 0.39 | d = 0.11 | d = 0.19 | |
|
| Baseline | 1.49 (0.88) | 1.11 (0.41) | 1.26 (0.60) | 1.88 (0.77) | 1.74 (0.90) | 0.84 (0.15) | 76.68 (15.35) |
| Post intervention | 1.37 (0.64) | 1.06 (0.25) | 1.16 (0.44) | 1.89 (0.78) | 1.58 (0.73) | 0.85 (0.13) | 80.48 (15.02) | |
| Paired | t = 2.18; | t = 1.57; | t = 2.57; | t = 0.93; | t = 2.67; | t = 0.88; | t = 1.11; | |
| ES: Cohen’s d | d = 0.16 | d = 0.14 | d = 0.19 | d = 0.02 | d = 0.20 | d = 0.07 | d = 0.25 | |
|
| Baseline | 1.62 (0.84) | 1.12 (0.52) | 1.26 (0.54) | 1.98 (0.84) | 1.55 (0.85) | 0.84 (0.14) | 73.15 (20.63) |
| Post intervention | 1.42 (0.65) | 1.06 (0.21) | 1.17 (0.52) | 1.97 (0.75) | 1.46 (0.76) | 0.83 (0.13) | 77.76 (18.54) | |
| Paired | t = 2.33; | t = 1.45; | t = 2.47; | t = 0.87; | t = 2.31; | t = 2.01; | t = 2.01; | |
| ES: Cohen’s d | d = 0.27 | d = 0.15 | d = 0.17 | d = 0.01 | d = 0.12 | d = 0.07 | d = 0.23 | |
Obs. VAS, visual analogic scale; ES, Effect Size. The Bonferroni correction for multiple comparisons was applied.